ExxonMobil Chemical New Separator Film Advance Next Generation of Hybrid and Electric Vehicles

ExxonMobil Chemical will introduce new co-extruded separator grades for hybrid and electric vehicle batteries at the Advanced Automotive Battery Conference (AABC) in Tampa, Florida on May 12-16, 2008.

In addition, Pat Brant, chief polymer scientist, ExxonMobil Chemical, will present a technical paper titled: “ExxonMobil Co-extrusion Separator Technology Platform for HEV/EV LIB”.

ExxonMobil Chemical and its Japanese affiliate, Tonen Chemical, have developed two new separator grades with co-extrusion technology to meet more demanding battery requirements. The new co-extruded grades offer enhanced permeability, improved strength, reduced heat shrinkage and higher rupture temperature to improve battery safety and performance.

“The two new co-extrusion grades have been developed to meet the different system needs for lithium-ion batteries in hybrid and electric vehicle applications,” said Jim P. Harris, senior vice president, ExxonMobil Chemical Company.

“We have now introduced four tailored battery separator films and are committed to extending our product portfolio to provide customers with the flexibility and versatility to make the next generation of lower emission vehicles possible.”

This technology platform builds on ExxonMobil Chemical’s twenty years of innovation and experience in lithium-ion battery separators. Production from existing commercial lines provides ExxonMobil Chemical with the flexibility to scale-up to meet the anticipated growth in demand for hybrid and electric vehicle batteries.

“ExxonMobil Chemical’s new battery separator film grades will help speed the adoption of smaller and more powerful lithium-ion batteries in next generation hybrid and electric vehicles,” said Harris.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.